Updated PoD Category Chart (7/22)
***NOTE: If you haven’t already, subscribe to this blog by hitting the Follow button on the right panel. You will then get an e-mail as soon as each new post goes up.
What better way to celebrate the first full week of the season’s unofficial second half than to post an updated Pitch or Ditch category chart!
For a number of years now, we have been posting these charts periodically throughout the season, and longtime 411 fan Big Barry deserves a special acknowledgement for suggesting the framework of the idea. For those unfamiliar with the format, in an effort to help you make those all important Pitch or Ditch decisions and determine whether or not a certain player deserves to remain on your roster, we have divided all of the pitchers currently in starting rotations into four groups: Aces, Grads, PoD and Indifferent. Keep in mind that the chart is geared towards standard 12-team mixed leagues. And of course, a pitcher’s designation will likely fluctuate throughout the season (especially between PoD and Grad). With each updated version of the chart, we will list the changes made since the previous version.
Aces – Elite starters with the track record to prove it. These pitchers should be in your active lineups regardless of the matchup.
Grads – Pitchers who aren’t ace material but should not be dropped and should be started in the vast majority of matchups.
PoD – Consider adding these guys off the waiver wire to start in favorable matchups, but feel free to drop them afterwards if you need the roster spot.
Indifferent – These pitchers are too risky to trust in any matchup and should remain on the waiver wire.
Here are the notable changes since the last version:
Salazar grad to ace
Moore PoD to grad
Bauer PoD to grad
Duffy PoD to grad
Shoemaker PoD to grad
Guerra PoD to grad
Leake PoD to grad
Graveman indifferent to PoD
Eovaldi grad to PoD
Smyly grad to PoD
Stroman grad to PoD
Shields grad to PoD
Chen grad to PoD
Nola grad to PoD
Ch. Anderson PoD to indifferent
Locke PoD to indifferent
And as always, your questions and comments are welcome.